Reaction
Hyphaema reporting signals
As of the last recalculation, Hyphaema appears in 518 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 65.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 40 | 65.5 | 65.6 |
| Prednisolone Acetate | 16 | 64.1 | 64.2 |
| Erythromycin | 26 | 58.6 | 58.7 |
| Phytonadione | 12 | 58.2 | 58.2 |
| Atropine Sulfate | 14 | 53.5 | 53.6 |
| Dorzolamide Hydrochloride And Timolol Maleate | 10 | 51.8 | 51.9 |
| Timolol Maleate | 12 | 49.8 | 49.9 |
| Meropenem | 34 | 45.5 | 45.5 |
| Atropine | 9 | 44.4 | 44.4 |
| Brinzolamide | 8 | 37.6 | 37.6 |
| Brimonidine Tartrate | 15 | 34.8 | 34.8 |
| Ganciclovir | 8 | 31.9 | 31.9 |
| Ganciclovir Sodium | 8 | 30.8 | 30.9 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 30.2 | 30.2 |
| Aflibercept | 22 | 29.5 | 29.6 |
| Clopidogrel Bisulfate | 62 | 27.5 | 27.6 |
| Alteplase | 10 | 27.3 | 27.3 |
| Timolol | 8 | 27.0 | 27.0 |
| Latanoprost | 31 | 26.3 | 26.3 |
| Faricimab | 4 | 20.0 | 20.0 |
| Bimatoprost | 11 | 15.6 | 15.7 |
| Dasatinib | 13 | 14.4 | 14.4 |
| Travoprost | 3 | 14.0 | 14.0 |
| Apalutamide | 3 | 10.3 | 10.3 |
| Cenegermin-Bkbj | 3 | 10.0 | 10.0 |